CCL

Összesen 16 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM089876
Első szerző:Allanore, Yannick
Cím:Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis : an analysis from the EUSTAR database / Yannick Allanore, Sylvie Bozzi, Augustin Terlinden, Doerte Huscher, Caroline Amand, Christina Soubrane, Elise Siegert, László Czirják, Patricia E. Carreira, Eric Hachulla, Elisabetta Zanatta, Mengtao Li, Paolo Airò, Fabian A. Mendoza, Edoardo Rosato, Oliver Distler, EUSTAR Collaborators
Dátum:2020
ISSN:1478-6354 1478-6362
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Arthritis Research & Therapy. - 22 (2020), p. 257-267. -
További szerzők:Bozzi, Sylvie Terlinden, Augustin Huscher, Dörte Amand, Caroline Soubrane, Christina Siegert, Elise Czirják László Carreira, Patricia E. Hachulla, Eric Zanatta, Elisabetta Li, Mengtao Airò, Paolo Mendoza, Fabian A. Rosato, Edoardo Distler, Oliver Szűcs Gabriella (1963-) (belgyógyász, allergológus és klinikai immunológus, reumatológus) EUSTAR
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM073990
Első szerző:Balogh Emese (reumatológus)
Cím:Oxidative stress impairs energy metabolism in primary cells and synovial tissue of patients with rheumatoid arthritis / Emese Balogh, Douglas J. Veale, Trudy McGarry, Carl Orr, Zoltan Szekanecz, Chin-Teck Ng, Ursula Fearon, Monika Biniecka
Dátum:2018
ISSN:1478-6354 1478-6362
Megjegyzések:BACKGROUND:In this study, we examined the effect of oxidative stress on cellular energy metabolism and pro-angiogenic/pro-inflammatory mechanisms of primary rheumatoid arthritis synovial fibroblast cells (RASFC) and human umbilical vein endothelial cells (HUVEC).METHODS:Primary RASFC and HUVEC were cultured with the oxidative stress inducer 4-hydroxy-2-nonenal (4-HNE), and extracellular acidification rate, oxygen consumption rate, mitochondrial function and pro-angiogenic/pro-inflammatory mechanisms were assessed using the Seahorse analyser, complex I-V activity assays, random mutation mitochondrial capture assays, enzyme-linked immunosorbent assays and functional assays, including angiogenic tube formation, migration and invasion. Expression of angiogenic growth factors in synovial tissue (ST) was assessed by IHC in patients with rheumatoid arthritis (RA) undergoing arthroscopy before and after administration of tumour necrosis factor inhibitors (TNFi).RESULTS:In RASFC and HUVEC, 4-HNE-induced oxidative stress reprogrammed energy metabolism by inhibiting mitochondrial basal, maximal and adenosine triphosphate-linked respiration and reserve capacity, coupled with the reduced enzymatic activity of oxidative phosphorylation complexes III and IV. In contrast, 4-HNE elevated basal glycolysis, glycolytic capacity and glycolytic reserve, paralleled by an increase in mitochondrial DNA mutations and reactive oxygen species. 4-HNE activated pro-angiogenic responses of RASFC, which subsequently altered HUVEC invasion and migration, angiogenic tube formation and the release of pro-angiogenic mediators. In vivo markers of angiogenesis (vascular endothelial growth factor, angiopoietin 2 [Ang2], tyrosine kinase receptor [Tie2]) were significantly associated with oxidative damage and oxygen metabolism in the inflamed synovium. Significant reduction in ST vascularity and Ang2/Tie2 expression was demonstrated in patients with RA before and after administration of TNFi.CONCLUSIONS:Oxidative stress promotes metabolism in favour of glycolysis, an effect that may contribute to acceleration of inflammatory mechanisms and subsequent dysfunctional angiogenesis in RA.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Bioenergetic metabolism
Oxidative stress
Angiogenesis
Rheumatoid arthritis
Megjelenés:Arthritis Research & Therapy. - 20 : 1 (2018), p. 1-15. -
További szerzők:Veale, Douglas J. McGarry, Trudy Orr, Carl Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus) Ng, Chin Teck Fearon, Ursula Biniecka, Monika
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM088823
Első szerző:Bütikofer, Lukas
Cím:ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis : a EUSTAR analysis / Bütikofer Lukas, Varisco Pierre A., Distler O., Kowal-Bielecka O., Allanore Y., Riemekasten G., Villiger P. M., Adler S., EUSTAR collaborators
Dátum:2020
ISSN:1478-6354 1478-6362
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Arthritis Research & Therapy. - 22 : 1 (2020), p. 1-9. -
További szerzők:Varisco, Pierre A. Distler, Oliver Kowal-Bielecka, Otylia Allanore, Yannick Riemekasten, Gabriela Villiger, P. M. Adler, S. Szűcs Gabriella (1963-) (belgyógyász, allergológus és klinikai immunológus, reumatológus) EUSTAR
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM115341
035-os BibID:(WoS)001123624500001 (Scopus)85179364233
Első szerző:Deibel, Elisabeth
Cím:Does the impact of COVID-19 on patients with systemic sclerosis change over time? / Deibel Elisabeth, Carreira Patricia E., Vonk Madelon, del Papa Nicoletta, Becvár Radim, Guillén-Del-Castillo Alfredo, Campochiaro Corrado, Poormoghim Hadi, Liem Sophie, Lazzaroni Maria-Grazia, Giollo Alessandro, Mekinian Arsene, de Vries-Bouwstra Jeska, De Santis Maria, Balbir-Gurman Alexandra, Mihai Carina, De Luca Giacomo, Moiseev Sergey, Zanatta Elisabetta, Foti Rosario, Rednic Simona, Denton Christopher, Cutolo Maurizio, Belloli Laura, Airo Paolo, Garzanova Liudmila, Moroncini Gianluca, Inanc Murat, Panopoulos Stylianos, Tandaipan Jose-Luis, Chatelus Emmanuel, Rosato Edoardo, Kuwana Masataka, Yavuz Sule, Alegre-Sancho Juan J., Smith Vanessa, Szűcs Gabriella, Henes Jörg, Rodríguez-Pintó Ignasi, Atzeni Fabiola, Spierings Julia, Truchetet Marie-Elise, Milchert Marcin, Brito de Araujo Daniel, Riemekasten Gabriela, Bernardino Vera, Martin Thierry, del Galdo Francesco, Vacca Alessandra, Mendoza Fabian, Midtvedt Øyvind, Murdaca Giuseppe, Santiago Tania, Codullo Veronica, Cacciapaglia Fabio, Walker Ulrich, Brunborg Cathrine, Tirelli Francesca, Allanore Yannick, Furst Daniel E., Matucci Marco, Gabrielli Armando, Distler Oliver, Hoffmann-Vold Anna-Maria
Dátum:2024
ISSN:2151-464X 2151-4658
Megjegyzések:Objective. The outcome of patients with COVID-19 improved over the pandemic, including patients with systemic rheumatic diseases. However, data on patients with systemic sclerosis (SSc) are lacking. This study aimed to assess the outcome of patients with both SSc and COVID-19 over several waves.Methods. Patients with both SSc and COVID-19 who were registered in the European Scleroderma Trials and Research group (EUSTAR) were collected between April 2020 and April 2021. Patients were assigned to waves 1, 2, or 3 depending on the date of their COVID-19 diagnosis. Primary endpoints were death, intensive care unit stay, or ventilatory support (severe outcome). Subgroup analyses of patients who were hospitalized or died were conducted. General and SSc-specific characteristics and treatment were compared over the waves. Descriptive statistics and multivariate logistic regression were applied.Results. A total of 333 patients were included; 57 patients (17%) had a severe outcome, and 30 patients (9%) died. Compared to wave 1, significantly fewer patients with SSc suffered from severe COVID-19 in waves 2 and 3 (28.2% vs 9.8% and 12.7%; P < 0.001), fewer patients required hospitalization (46.7% vs 19.6% and 25.5%; P < 0.001) or ventilatory support (24.0% vs 8.7% and 10.9%; P = 0.001), and fewer patients died (15.7% vs 5.0% and 7.5%; P = 0.011). Patients were significantly younger, more often men, had less frequent arterial hypertension, and less SSc cardiac involvement over waves 1 to 3. Patients received significantly less medium to high doses of corticosteroids as they did SSc treatment.Conclusion. The outcome of patients with both SSc and COVID-19 improved significantly over time because of intrinsic and extrinsic factors.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Arthritis Care And Research. - 76 : 1 (2024), p. 88-97. -
További szerzők:Carreira, Patricia E. Vonk, Madelon C. del Papa, Nicoletta Becvar, Radim Guillén-Del-Castillo, Alfredo Campochiaro, Corrado Poormoghim, Hadi Liem, Sophie Lazzaroni, Maria-Grazia Giollo, Alessandro Mekinian, Arsene de Vries-Bouwstra, Jeska De Santis, Maria Balbir Gurman, Alexandra Mihai, Carina De Luca, Giacomo Moiseev, Sergey Zanatta, Elisabetta Foti, Rosario Rednic, Simona Denton, Christopher Cutolo, Maurizio Belloli, Laura Airò, Paolo Garzanova, Liudmila Moroncini, Gianluca Inanc, M. Panopoulos, Stylianos Tandaipan, José-Luis Chatelus, Emmanuel Rosato, Edoardo Kuwana, Masataka Yavuz, Sule Alegre-Sancho, Juan Jose Smith, Vanessa Szűcs Gabriella (1963-) (belgyógyász, allergológus és klinikai immunológus, reumatológus) Henes, Jörg Rodríguez-Pintó, Ignasi Atzeni, Fabiola Spierings, Julia Truchetet, Marie-Elise Milchert, Marcin Brito de Araujo, Daniel Riemekasten, Gabriela Bernardino, Vera Martin, Thierry del Galdo, Francesco Vacca, Alessandra Mendoza, Fabian A. Midtvedt, Øyvind Murdaca, Giuseppe Santiago, Tania Codullo, Veronica Cacciapaglia, Fabio Walker, Ulrich Brunborg, Cathrine Tirelli, Francesca Allanore, Yannick Furst, Daniel E. Matucci-Cerinic, Marco Gabrielli, Armando Distler, Oliver Hoffmann-Vold, Anna-Maria
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

5.

001-es BibID:BIBFORM038798
Első szerző:Dougados, Maxime
Cím:Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers : example of etanercept in advanced ankylosing spondylitis / Dougados Maxime, Braun Jurgen, Szanto Sandor, Combe Bernard, Geher Pal, Leblanc Véronique, Logeart Isabelle
Dátum:2012
ISSN:2151-464X
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Arthritis Care & Research. - 64 : 2 (2012), p. 290-294. -
További szerzők:Braun, Jurgen Szántó Sándor (1968-) (belgyógyász, reumatológus) Combe, Bernard Géher Pál Leblanc, Véronique Logeart, Isabelle
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

6.

001-es BibID:BIBFORM082302
Első szerző:Horváth Ágnes (reumatológus)
Cím:Complex assessment of bone mineral density, fracture risk, vitamin D status and bone metabolism in Hungarian systemic sclerosis patients / Ágnes Horváth, Edit Végh, Anita Pusztai, Zsófia Pethő, Attila Hamar, Monika Czókolyová, Harjit Pal Bhattoa, Gábor Nagy, Balázs Juhász, Katalin Hodosi, Andrea Domján, Zoltán Szekanecz, Gabriella Szücs, Szilvia Szamosi
Dátum:2019
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Arthritis Research & Therapy. - 21 : 1 (2019), p. 1-10. -
További szerzők:Végh Edit (1978-) (reumatológus, belgyógyász) Karancsiné Pusztai Anita (1989-) (tudományos segédmunkatárs) Pethő Zsófia (1981-) (reumatológus, immunológus) Hamar Attila Béla (1990-) (általános orvos) Czókolyová Mónika (1993-) (molekuláris biológus) Bhattoa Harjit Pal (1973-) (laboratóriumi szakorvos) Nagy Gábor (1974-) (laboratóriumi szakorvos, laboratóriumi hematológus és immunológus) Juhász Balázs (1973-) (orvos, onkológus) Hódosi Katalin Domján Andrea (1979-) (reumatológus) Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus) Szűcs Gabriella (1963-) (belgyógyász, allergológus és klinikai immunológus, reumatológus) Szamosi Szilvia (1975-) (belgyógyász, reumatológus)
Pályázati támogatás:TAMOP-4.2.4.A/2-11/1-2012-14 0001'National Excellence Program'
TAMOP
GINOP-2.3.2- 15-2016-00015
GINOP
GINOP-2.3.2-15-2016-00050
GINP
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

7.

001-es BibID:BIBFORM084878
Első szerző:Oláh Csaba (idegsebész)
Cím:Cognitive dysfunction in autoimmune rheumatic diseases / Oláh Csaba, Schwartz Noa, Denton Christopher, Kardos Zsófia, Putterman Chaim, Szekanecz Zoltán
Dátum:2020
ISSN:1478-6354 1478-6362
Megjegyzések:For people with chronic autoimmune rheumatic diseases (AIRD), such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or systemic sclerosis (SSc), normal cognitive functions are essential for performing daily activities. These diseases may be associated with cognitive dysfunction (CD). In RA, CD has been associated with age, lower education and disease duration and activity. Great advances have been achieved in neuropsychiatric SLE in the identification of pathogenic pathways, assessment and possible treatment strategies. SSc rarely exerts direct effects on the brain and cognitive function. However, the psychological burden that includes depression, anxiety and social impact may be high. AIRD patients with sustained disease activity, organ damage or lower education should be evaluated for CD. The control of systemic inflammation together with tailored behavioural cognitive therapies may benefit these patients.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Cognitive function
Cognitive dysfunction
Rheumatoid arthritis
Systemic lupus erythematosus
Neuropsychiatric lupus
Systemic sclerosis
Megjelenés:Arthritis Research & Therapy. - 22 : 1 (2020), p. 1-7. -
További szerzők:Schwartz, Noa Denton, Christopher Kardos Zsófia Putterman, Chaim Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus)
Pályázati támogatás:TAMOP-4.2.4.A/2-11/1-2012-0001
TÁMOP
GINOP-2.3.2-15-2016-00015
GINOP
GINOP-2.3.2-15-2016-00050
GINOP
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

8.

001-es BibID:BIBFORM070695
Első szerző:Oláh Csaba (idegsebész)
Cím:Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis / Csaba Oláh, Zsófia Kardos, Mariann Sepsi, Attila Sas, László Kostyál, Harjit Pal Bhattoa, Katalin Hodosi, György Kerekes, László Tamási, Attila Valikovics, Dániel Bereczki, Zoltán Szekanecz
Dátum:2017
ISSN:1478-6354 1478-6362
Megjegyzések:Background: Stroke has been associated with rheumatoid arthritis (RA). We assessed patients with RA and healthycontrol subjects by transcranial Doppler (TCD), carotid ultrasonography and brain magnetic resonance imaging (MRI).Methods: Altogether, 41 female patients with RA undergoing methotrexate (MTX) or biologic treatment and 60age-matched control subjects underwent TCD assessment of the middle cerebral artery (MCA) and basilar artery.Pulsatility index (PI), resistivity (resistance) index (RI) and circulatory reserve capacity (CRC) were determined at rest (r)and after apnoea (a) and hyperventilation (h). The presence of carotid plaques and carotid intima-media thickness(cIMT) were also determined. Intracerebral vascular lesions were investigated by brain MRI.Results: MCA PI and RI values at rest and after apnoea were significantly increased in the total and MTX-treated RApopulations vs control subjects. MCA CRC was also impaired, and basilar artery PI was higher in RA. More patientswith RA had carotid plaques and increased cIMT. Linear regression analysis revealed that left PI(r) and RI(r) correlatedwith disease duration and that left PI(r), RI(r), PI(a), PI(h) and basilar PI correlated with disease activity. Right CRCinversely correlated with 28-joint Disease Activity Score. Disease activity was an independent determinant of left PI(a)and right CRC. Compared with long-term MTX treatment alone, the use of biologics in combination with MTX wasassociated with less impaired cerebral circulation. Impaired cerebral circulation was also associated with measures ofcarotid atherosclerosis.Conclusions: To our knowledge, this is the first study to show increased distal MCA and basilar artery occlusion in RAas determined by TCD. Patients with RA also had CRC defects. We also confirmed increased carotid plaque formationand increased cIMT. Biologics may beneficially influence some parameters in the intracranial vessels.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Arthritis Research & Therapy 19 : 1 (2017), p. 213. -
További szerzők:Kardos Zsófia Sepsi Marianna Sas Attila Kostyál László (1974-) (radiológus) Bhattoa Harjit Pal (1973-) (laboratóriumi szakorvos) Hódosi Katalin Kerekes György (1973-) (belgyógyász, kardiológus, angiológus) Tamási László Valikovics Attila Bereczki Dániel (1960-) (neurológus) Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

9.

001-es BibID:BIBFORM078224
Első szerző:Póliska Szilárd (biológus)
Cím:Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis / Szilárd Póliska, Timea Besenyei, Edit Végh, Attila Hamar, Anita Pusztai, Andrea Váncsa, Nóra Bodnár, Szilvia Szamosi, Mária Csumita, György Kerekes, Zoltán Szabó, Zoltán Nagy, Gabriella Szűcs, Sándor Szántó, Gábor Zahuczky, László Nagy, Zoltán Szekanecz
Dátum:2019
ISSN:1478-6354 1478-6362
Megjegyzések:Objectives: Impaired vascular pathophysiology and increased cardiovascular (CV) mortality are associated with rheumatoid arthritis (RA). To date, no genomic analysis of RA- and RA treatment-related vascular pathophysiology has been published. In this pilot study, we performed gene expression profiling in association with vascular pathophysiology in RA patients. Methods: Sixteen and 19 biologic-naïve RA patients were included in study 1 and study 2, respectively. In study 1, genetic signatures determined by microarray were related to flow-mediated vasodilation (FMD), pulse-wave velocity (PWV), and common carotid intima-media thickness (IMT) of patients. In study 2, clinical response (cR) vs non-response (cNR) to 1-year etanercept (ETN) or certolizumab pegol (CZP) treatment, as well as "vascular" response (vR) vs non-response (vNR) to biologics, were also associated with genomic profiles. Multiple testing could not be performed due to the relatively small number of patients; therefore, our pilot study may lack power. Results: In study 1, multiple genes were up- or downregulated in patients with abnormal vs normal FMD, IMT, and PWV. In study 2, there were 13 cR and 6 cNR anti-tumor necrosis factor (TNF)-treated patients. In addition, 10, 9, and 8 patients were FMD-20%, IMT-20%, and PWV-20% responders. Again, vascular responder status was associated with changes of the expression of various genes. The highest number of genes showing significant enrichment were involved in positive regulation of immune effector process, regulation of glucose transport, and Golgi vesicle budding. Conclusion: Differential expression of multiple genetic profiles may be associated with vascular pathophysiology associated with RA. Moreover, distinct genetic signatures may also be associated with clinical and vascular responses to 1-year anti-TNF treatment.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Arthritis Research & Therapy. - 21 : 1 (2019), p. 94. -
További szerzők:Besenyei Tímea (1980-) (reumatológus, belgyógyász) Végh Edit (1978-) (reumatológus, belgyógyász) Hamar Attila Béla (1990-) (általános orvos) Karancsiné Pusztai Anita (1989-) (tudományos segédmunkatárs) Váncsa Andrea (1972-) (orvos) Bodnár Nóra (1980-) (reumatológus) Szamosi Szilvia (1975-) (belgyógyász, reumatológus) Csumita Mária (1989-) (biomérnök) Kerekes György (1973-) (belgyógyász, kardiológus, angiológus) Szabó Zoltán (1970-) (belgyógyász, reumatológus) Nagy Zoltán (orvos) Szűcs Gabriella (1963-) (belgyógyász, allergológus és klinikai immunológus, reumatológus) Szántó Sándor (1968-) (belgyógyász, reumatológus) Zahuczky Gábor (1975-) (molekuláris biológus, biokémikus, vegyész) Nagy László (1966-) (molekuláris sejtbiológus, biokémikus) Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus)
Pályázati támogatás:K10073
OTKA
TAMOP-4.2.4.A/2-11/1-2012-0001
TÁMOP
GINOP-2.3.2-15-2016-00015
GINOP
GINOP-2.3.2-15-2016-00050
GINOP
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

10.

001-es BibID:BIBFORM007092
Első szerző:Szántó Sándor (belgyógyász, reumatológus)
Cím:Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice / Szanto, S., Koreny, T., Mikecz, K., Glant, T. T., Szekanecz, Z., Varga, J.
Dátum:2007
ISSN:1478-6362 (Electronic)
Megjegyzések:Indoleamine 2,3-dioxygenase (IDO) is one of the initial and rate-limiting enzymes involved in the catabolism of the essential amino acid tryptophan. In cultured cells, the induction of IDO leads to depletion of tryptophan and tryptophan starvation. Recent studies suggest that modulation of tryptophan concentration via IDO plays a fundamental role in innate immune responses. Induction of IDO by interferon-gamma in macrophages and dendritic cells results in tryptophan depletion and suppresses the immune-mediated activation of fibroblasts and T, B, and natural killer cells. To assess the role of IDO in collagen-induced arthritis (CIA), a model of rheumatoid arthritis characterized by a primarily Th1-like immune response, activity of IDO was inhibited by 1-methyl-tryptophan (1-MT) in vivo. The results showed significantly increased incidence and severity of CIA in mice treated with 1-MT. Activity of IDO, as determined by measuring the levels of kynurenine/tryptophan ratio in the sera, was increased in the acute phase of arthritis and was higher in collagen-immunized mice that did not develop arthritis. Treatment with 1-MT resulted in an enhanced cellular and humoral immune response and a more dominant polarization to Th1 in mice with arthritis compared with vehicle-treated arthritic mice. The results demonstrated that development of CIA was associated with increased IDO activity and enhanced tryptophan catabolism in mice. Blocking IDO with 1-MT aggravated the severity of arthritis and enhanced the immune responses. These findings suggest that IDO may play an important and novel role in the negative feedback of CIA and possibly in the pathogenesis of rheumatoid arthritis.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Animals
Arthritis, Experimental
Chromatography, High Pressure Liquid
Feedback, Biochemical
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase
Interleukin-2
Kynuramine/blood
Mice
Mice, Inbred DBA
T-Lymphocytes
Tryptophan/analogs and derivatives
Megjelenés:Arthritis Research and Therapy. - 9 : 3 (2007), p. R50. -
További szerzők:Koreny Tamás Mikecz Katalin Glant Tibor T. Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus) Varga John
Internet cím:elektronikus változat
DOI
elektronikus változat
Borító:

11.

001-es BibID:BIBFORM076709
Első szerző:Szekanecz Zoltán (reumatológus, belgyógyász, immunológus)
Cím:Common mechanisms and holistic care in atherosclerosis and osteoporosis / Zoltán Szekanecz, Hennie G. Raterman, Zsófia Pethő, Willem F. Lems
Dátum:2019
ISSN:1478-6354 1478-6362
Megjegyzések:Cardiovascular (CV) disease and osteoporosis (OP) have become increasing challenges in the aging population and even more in patients with inflammatory rheumatic diseases, such as rheumatoid arthritis, spondyloarthropathies, and systemic lupus erythematosus. In this review, we discuss how the epidemiology and pathogenesis of CV events and OP are overlapping. Smoking, diabetes mellitus, physical inactivity as conventional risk factors as well as systemic inflammation are among the modifiable risk factors for both CV events and bone loss. In rheumatic patients, systemic "high-grade" inflammation may be the primary driver of accelerated atherogenesis and bone resorption. In the general population, in which some individuals might have low-grade systemic inflammation, a holistic approach to drug treatment and lifestyle modifications may have beneficial effects on the bone as well as the vasculature. In rheumatic patients with accelerated inflammatory atherosclerosis and bone loss, the rapid and effective suppression of inflammation in a treat-to-target regime, aiming at clinical remission, is necessary to effectively control comorbidities.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Atherosclerosis
Osteoporosis
Bone loss
Inflammation
Risk factors
DXA
Rheumatoid arthritis
Megjelenés:Arthritis Research & Therapy. - 21 : 1 (2019), p. 1-10. -
További szerzők:Raterman, Hennie G. Pethő Zsófia (1981-) (reumatológus, immunológus) Lems, Willem F.
Pályázati támogatás:TAMOP-4.2.4.A/2-11/1-2012-0001
TÁMOP
GINOP-2.3.2-15-2016-00015
GINOP
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

12.

001-es BibID:BIBFORM070459
Első szerző:Szekanecz Zoltán (reumatológus, belgyógyász, immunológus)
Cím:Opportunities and challenges in rheumatology research in Central Europe / Szekanecz Zoltán, Anic Branimir, Héjj Gábor, Holc Iztok, Hunka Aniella, Kucharz Eugene, Machold Klaus, Mayer Miroslav, Pahor Artur, Puchner Rudolf, Rovensky Jozef, Senolt Ladislav, Tuchynova Alena, Vencovsky Jiri, Smolen Josef S.
Dátum:2017
ISSN:1478-6354 1478-6362
Megjegyzések:The Central European Congress of Rheumatology(CECR) has been organized by seven Central Europeancountries: Austria, Croatia, Czech Republic, Hungary,Poland, Slovakia, and Slovenia. These countries havelots of similarities, but also differences, with respectto rheumatology research. In this paper, based onquestionnaires, we wish to demonstrate achievementsand difficulties in rheumatology research performedin our region.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Central Europe
Rheumatology
Research
Funding
Arthritis
Collaboration
Megjelenés:Arthritis Research & Therapy 19 : 196 (2017), p. 1-4. -
További szerzők:Anic, Branimir Héjj Gábor Holc, Iztok Hunka Aniella Kucharz, Eugene Machold, Klaus Mayer, Miroslav Pahor, Artur Puchner Rudolf Rovensky, Josef Senolt, Ladislav Tuchynova, Alena Vencovsky, Jiri Smolen, Josef S.
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1 2 
Corvina könyvtári katalógus v8.2.27 © 2023 Monguz kft. Minden jog fenntartva.